AU6593196A - Determination of the presence of abnormal cellular proliferation through the detection of one or more cyclin dependent kinases - Google Patents

Determination of the presence of abnormal cellular proliferation through the detection of one or more cyclin dependent kinases

Info

Publication number
AU6593196A
AU6593196A AU65931/96A AU6593196A AU6593196A AU 6593196 A AU6593196 A AU 6593196A AU 65931/96 A AU65931/96 A AU 65931/96A AU 6593196 A AU6593196 A AU 6593196A AU 6593196 A AU6593196 A AU 6593196A
Authority
AU
Australia
Prior art keywords
determination
detection
cellular proliferation
cyclin dependent
dependent kinases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65931/96A
Inventor
John G Babish
Brian E. Johnson
Xingfang Ma
Joseph Rininger
Judith A. St. Leger
Debra S. Whiting
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paracelsian Inc
Original Assignee
Paracelsian Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paracelsian Inc filed Critical Paracelsian Inc
Publication of AU6593196A publication Critical patent/AU6593196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU65931/96A 1995-07-20 1996-07-19 Determination of the presence of abnormal cellular proliferation through the detection of one or more cyclin dependent kinases Abandoned AU6593196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50453295A 1995-07-20 1995-07-20
US504532 1995-07-20
PCT/US1996/012070 WO1997004316A1 (en) 1995-07-20 1996-07-19 Determination of the presence of abnormal cellular proliferation through the detection of one or more cyclin dependent kinases

Publications (1)

Publication Number Publication Date
AU6593196A true AU6593196A (en) 1997-02-18

Family

ID=24006679

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65931/96A Abandoned AU6593196A (en) 1995-07-20 1996-07-19 Determination of the presence of abnormal cellular proliferation through the detection of one or more cyclin dependent kinases

Country Status (2)

Country Link
AU (1) AU6593196A (en)
WO (1) WO1997004316A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017413A1 (en) * 1993-01-21 1994-08-04 Paracelsian, Inc. Products for measuring cell growth propensity and methods for their use
GB2334579B (en) * 1998-02-18 2003-06-04 Univ Liverpool Treating cancer
GB2334578A (en) * 1998-02-18 1999-08-25 Univ Liverpool Diagnosis of cancer involving assay of levels of cyclin-dependent kinase (CDK) isoenzymes
GB2335739A (en) * 1998-02-18 1999-09-29 Univ Liverpool Screening anti-cancer agents
AU741632B2 (en) * 1998-02-18 2001-12-06 Theryte Limited Treating cancer
US6780596B2 (en) * 1998-09-17 2004-08-24 Ashni Naturaceuticals, Inc. Methods for determining the activity of complex mixtures
WO2004076686A1 (en) * 2003-02-26 2004-09-10 Sysmex Corporation Method of examining cell

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017413A1 (en) * 1993-01-21 1994-08-04 Paracelsian, Inc. Products for measuring cell growth propensity and methods for their use

Also Published As

Publication number Publication date
WO1997004316A1 (en) 1997-02-06

Similar Documents

Publication Publication Date Title
WO1998035012A3 (en) Methods and products for analyzing polymers
ZA9810332B (en) Aminothiazone inhibitors of cyclin dependent kinases.
AU691272B2 (en) Receiver and transmitter-receiver
AU4311896A (en) Authentication of articles
AU8908998A (en) Analyte detection systems
AU4612596A (en) Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore
AU2375597A (en) The detection of airborne pollutants
AU1536799A (en) Bishydroxyureas as inhibitors of the 5-lipoxygenase
AU4973896A (en) Ink4c-p18 and ink4d-p19, inhibitors of cyclin-depedent kinases cdk4 and cdk6, and uses thereof
AU4296397A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU3769097A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU2438397A (en) Methods of determining the risk of pouchitis development
AU1893095A (en) Sensitive cancer test
AU1313300A (en) Range measuring system
AU3094197A (en) Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
AU5110296A (en) Arrangement for the detection of targets
AUPM769394A0 (en) Assay for the detection of proteases
AU3673497A (en) Detection of microbacteria
AU6593196A (en) Determination of the presence of abnormal cellular proliferation through the detection of one or more cyclin dependent kinases
AU4324397A (en) Detection of microorganisms
AU3526295A (en) Detection of spread spectrum signals
AU6545296A (en) Methods and articles of manufacture for the detection of cryptosporidium oocysts
AUPN366895A0 (en) Detection of small analytes
AU6354299A (en) Dip-stick detection system
AU4994399A (en) System for testing properties of materials